Phasing out the pre-transplant cytotoxicity crossmatch: Are we missing something?

Phasing out the pre-transplant cytotoxicity crossmatch: Are we missing something?

Abstract Introduction: The anti-human globulin-enhanced complement-dependent cytotoxicity crossmatch (AHG-CDCXM) assay has been used to assess the presence of donor-specific antibodies (DSA) in recipient’s serum before kidney transplantation. The flow cytometric crossmatch (FCXM) assay was first i...

Full description

Bibliographic Details
Main Authors: Jamile Abud, Bruna Brasil Dal Pupo, Cynthia da Silva, Elizete Keitel, Valter Duro Garcia, Roberto Ceratti Manfro, Jorge Neumann
Format: Article
Language:English
Published: Sociedade Brasileira de Nefrologia 2021-04-01
Series:Brazilian Journal of Nephrology
Subjects:
Flow Cytometry
Cytotoxicity Tests, Immunologic
Graft Rejection
Transplante.
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021000300365&tlng=pt

Similar Items

Similar Items